Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1335, 2002-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Standard short-course TB therapy not enough?
Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. :
Access to resources
Recommend
TB drug susceptibility testing strategies: which is best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 636, 2011-01 ,pp. :
Mycobacterium vaccae vaccine in HIV-positive pulmonary TB?
Inpharma, Vol. 1, Iss. 1356, 2002-01 ,pp. :
Is DOTS-plus worth it for TB in developing countries?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 404, 2003-01 ,pp. :
No longer a world of `Prozac' nations?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 361, 2002-01 ,pp. :